| Absorption |
| Blood-Brain Barrier | BBB- | 0.9918 |
| Human Intestinal Absorption | HIA- | 0.9213 |
| Caco-2 Permeability | Caco2+ | 0.8867 |
| P-glycoprotein Substrate | Substrate | 0.5543 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9052 |
| Non-inhibitor | 0.9543 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9423 |
| Distribution |
| Subcellular localization | Lysosome | 0.6219 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8983 |
| CYP450 2D6 Substrate | Non-substrate | 0.8513 |
| CYP450 3A4 Substrate | Non-substrate | 0.5094 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.7960 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9283 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9996 |
| Non-inhibitor | 0.8150 |
| AMES Toxicity | Non AMES toxic | 0.8164 |
| Carcinogens | Non-carcinogens | 0.6461 |
| Fish Toxicity | High FHMT | 0.9666 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9226 |
| Honey Bee Toxicity | Low HBT | 0.6107 |
| Biodegradation | Not ready biodegradable | 0.9769 |
| Acute Oral Toxicity | IV | 0.6130 |
| Carcinogenicity (Three-class) | Non-required | 0.6503 |